- Reuters•7 hours ago
A unit of Botox maker Allergan Plc will pay a $15 million penalty and admit to wrongdoing, after U.S. regulators on Tuesday accused the unit of failing to disclose 2014 merger talks with Actavis, the U.S. Securities and Exchange Commission said. In a statement on Tuesday, the SEC said that the disclosure failures occurred in the months after the company received a tender offer from Valeant Pharmaceuticals International and co-bidder Pershing Square Capital Management, the hedge fund run by Bill Ackman.
- Investopedia•11 hours ago
Healthcare stocks are falling again ahead of Friday's transition of power.
- Investopedia•14 hours ago
Allergan's shares are falling about two percent to start the day despite positive Phase III trial results.
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||211.43 - 215.88|
|52 Week Range||184.50 - 301.98|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.02|
|Dividend & Yield||2.80 (1.30%)|
|1y Target Est||N/A|